Spectrum Pharmaceuticals/ US84763A1088 /
| 2023-07-31 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.03USD | - | 122,550 Turnover: 124,444.33 |
-Bid Size: - | -Ask Size: - | 211.42 mill.USD | - | - |
Assets
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1.5000 | 1.4050 | .9180 | .4490 | .5890 | ||||||
| Intangible Assets | 231.4000 | 230.1000 | 190.3350 | 164.2340 | 137.1590 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | 267.5640 | 229.8960 | 212.1180 | 209.6930 | ||||||
| Inventories | 13.5000 | 9.2000 | 4.1760 | 8.7150 | 5.7150 | ||||||
| Accounts Receivable | 49.5000 | 70.7580 | 30.3840 | 39.7820 | 32.2600 | ||||||
| Cash and Cash Equivalents | 156.3000 | 129.9420 | 139.7410 | 158.2220 | 227.3230 | ||||||
| Current Assets | 235.2000 | 222.4690 | 191.3240 | 216.6500 | 277.7460 | ||||||
| Total Assets | 499.2000 | 490.0330 | 421.2200 | 428.7680 | 487.4390 | ||||||
Liabilities
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 79.8000 | 8.9940 | 26.6840 | 30.4880 | 33.6480 | ||||||
| Long-term debt | - | 96.2980 | 101.5480 | 97.0430 | 0.0000 | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Provisions | 7.2000 | 6.6000 | 6.8000 | 6.7000 | 1.4000 | ||||||
| Liabilities | 217.5000 | 235.4790 | 208.3630 | 192.7420 | 136.1000 | ||||||
| Share Capital | .0640 | .0660 | .0680 | .0800 | .1000 | ||||||
| Total Equity | 281.6000 | 254.5540 | 212.8570 | 236.0260 | 351.3390 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 499.2000 | 490.0330 | 421.2200 | 428.7680 | 487.4390 | ||||||
Income Statement
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 155.9000 | 186.8300 | 162.5560 | 146.4440 | 128.3670 | ||||||
| Depreciation (total) | 20.1000 | 25.3520 | 31.8690 | 26.4920 | 27.9720 | ||||||
| Operating Result | -38.8000 | -31.5690 | -40.7320 | -61.6280 | -96.6600 | ||||||
| Interest Income | -2.2000 | -8.5840 | -9.0740 | -9.4350 | -6.7980 | ||||||
| Income Before Taxes | -36.6000 | -43.5330 | -50.3790 | -70.8250 | -108.0260 | ||||||
| Income Taxes | 25.5000 | -2.1860 | -.4060 | 2.3130 | 16.7780 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -62.1000 | -45.7190 | -50.7850 | -68.5120 | -91.2480 | ||||||
Per Share
Cash Flow
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -2.1000 | -3.6270 | 6.7440 | -40.4590 | -38.8550 | ||||||
| Cash Flow from Investing Activities | -14.3000 | -21.8410 | 2.8380 | -.6790 | -1.0810 | ||||||
| Cash Flow from Financing | 35.3000 | .8120 | 1.4710 | 59.6440 | 108.7210 | ||||||
| Decrease / Increase in Cash | 16.6000 | -26.3640 | 9.7990 | 18.4810 | 69.1010 | ||||||
| Employees | 226 | 241 | 212 | 227 | 215 | ||||||
